Here are six key obstacles states are struggling to overcome as they prepare their plans:
- Determining who is eligible to receive the first doses.
- Assuring masses of increasingly apprehensive citizens that the shots are safe.
- Transporting vaccines from drugmakers to healthcare facilities.
- Combining the federal government’s top-down guidance with a mostly bottom-up delivery system.
- Storing Pfizer and BioNTech’s vaccine, which must be kept at -94 degrees.
- Tracking who received the vaccine, as well as when and where, as most of the vaccine candidates require two doses weeks apart.
More articles on pharmacy:
J&J pauses COVID-19 vaccine trial over participant’s ‘unexplained illness’
HHS fund protects drugmakers from coronavirus vaccine-related liabilities
Eli Lilly halts COVID-19 antibody drug trial over safety concern